Related Experiment Video
Updated: Dec 26, 2025

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
The role of myelin damage in Alzheimer's disease pathology
Ewa Papuć1, Konrad Rejdak1,2
1Department of Neurology, Medical University of Lublin, Lublin, Poland.
Abstract:
Although Alois Alzheimer described myelin disruption in Alzheimer's disease (AD) as early as in 1911, his observation has escaped the attention of researchers since that time. Alzheimer's disease has been mainly considered as a grey matter disorder; nevertheless, recent evidence suggests that myelin impairment may play an important role in AD pathology. Classical neuropathological changes in AD, e.g. the accumulation of aggregated Aβ 42 and the presence of neurofibrillary tangles, are responsible for neuronal loss, but they may also induce death of oligodendrocytes and myelin damage. There is also evidence that myelin pathology may even precede Aβ and tau pathologies in AD. The state of the art does not allow us to determine whether myelin damage is a primary or a secondary injury in AD subjects. The article presents an overview of current knowledge on the role of myelin in AD pathology and its interactions with Aβ and tau pathologies.
Insights
Myelin damage, overlooked for decades in Alzheimer's disease (AD), is now recognized as crucial. This review explores myelin's role and interaction with amyloid-beta and tau pathologies in AD.
Area of Science:
- Neuroscience
- Neuropathology
- Demyelinating Diseases
Background:
- Alzheimer's disease (AD) has historically been viewed as a grey matter disorder.
- Alois Alzheimer's early 1911 observation of myelin disruption in AD was largely ignored.
- Emerging evidence highlights the significant role of myelin impairment in AD pathology.
Purpose of the Study:
- To provide an overview of the current understanding of myelin's role in Alzheimer's disease.
- To examine the interactions between myelin pathology and hallmark AD pathologies (Aβ and tau).
- To discuss whether myelin damage is a primary or secondary event in AD.
Main Methods:
- Review of existing literature on myelin pathology in Alzheimer's disease.
- Analysis of the relationship between myelin damage and Aβ/tau accumulation.
- Synthesis of evidence regarding the temporal sequence of pathological events in AD.
Main Results:
- Oligodendrocyte death and myelin damage can be induced by classical AD neuropathological changes (Aβ plaques, neurofibrillary tangles).
- Myelin pathology may precede the development of Aβ and tau pathologies in some cases of AD.
- The precise causal relationship (primary vs. secondary injury) of myelin damage in AD remains undetermined.
Conclusions:
- Myelin disruption is an important, though historically underappreciated, feature of Alzheimer's disease pathology.
- Understanding myelin's role is critical for a comprehensive view of AD pathogenesis.
- Further research is needed to elucidate the exact timing and contribution of myelin damage in AD progression.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

